Novartis Names Fitzpatrick As A Preferred U.S. Intellectual Property Firm

July 16, 2012

Novartis has selected Fitzpatrick, Cella, Harper & Scinto to its Legal Preferred Firm Panel as a U.S. specialist law firm for intellectual property matters. According to Novartis, its legal preferred program is “intended to achieve the best legal and business results for Novartis through the development of longer-term, strategic partnerships with law firms.” Fitzpatrick has represented Novartis’ brand pharmaceutical companies, and its predecessor Sandoz prior to its merger with Ciba-Geigy, for over 30 years.

View Attachment (PDF)